Cargando…

The course of neuropsychiatric symptoms and psychotropic drug use in Dutch nursing home patients with dementia during the first wave of COVID‐19: A longitudinal cohort study

OBJECTIVE: To describe the course of neuropsychiatric symptoms in nursing home residents with dementia during the step‐by‐step lifting of restrictions after the first wave of the COVID‐19 pandemic in the Netherlands, and to describe psychotropic drug use (PDU) throughout the whole first wave. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sizoo, Eefje M., Thunnissen, Josi A., van Loon, Anouk M., Brederveld, Claire L., Timmer, Helma, Hendriks, Simone, Smalbrugge, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087381/ https://www.ncbi.nlm.nih.gov/pubmed/35191093 http://dx.doi.org/10.1002/gps.5693

Ejemplares similares

The Recovery After COVID-19 in Nursing Home Residents
por: van der Krogt, Inge E. J., et al.
Publicado: (2022)

Advance Care Planning in Dutch Nursing Homes During the First Wave of the COVID-19 Pandemic
por: ter Brugge, Bastiaan P.H., et al.
Publicado: (2022)

Psychotropic drug treatment for agitated behaviour in dementia: what if the guideline prescribing recommendations are not sufficient? A qualitative study
por: Dijk, Margaretha T, et al.
Publicado: (2022)

Dilemmas With Restrictive Visiting Policies in Dutch Nursing Homes During the COVID-19 Pandemic: A Qualitative Analysis of an Open-Ended Questionnaire With Elderly Care Physicians
por: Sizoo, Eefje M., et al.
Publicado: (2020)

Time trends in psychotropic drug prescriptions in Dutch nursing home residents with dementia between 2003 and 2018
por: Du, Jiamin, et al.
Publicado: (2022)

Prevalence and correlates of psychotropic drug use in Dutch nursing home patients with young‐onset dementia
por: Mulders, Ans J.M.J., et al.
Publicado: (2019)

Process evaluation of a tailored intervention to Reduce Inappropriate psychotropic Drug use in nursing home residents with dementia
por: Groot Kormelinck, Claudia M., et al.
Publicado: (2021)

Dealing with requests for euthanasia in incompetent patients with dementia. Qualitative research revealing underexposed aspects of the societal debate
por: Coers, Djura O, et al.
Publicado: (2023)

Improving psychotropic drug prescription in nursing home patients with dementia: design of a cluster randomized controlled trial
por: Smeets, Claudia HW, et al.
Publicado: (2013)

Clinical evaluation of single-swab sampling for rapid COVID-19 detection in outbreak settings in Dutch nursing homes
por: Paap, Kelly C., et al.
Publicado: (2021)

Implementing a Personalized Integrated Stepped-Care Method (STIP-Method) to Prevent and Treat Neuropsychiatric Symptoms in Persons With Dementia in Nursing Homes: Protocol for a Mixed Methods Study
por: Verstraeten, Helma M F, et al.
Publicado: (2022)

Reducing inappropriate psychotropic drug use in nursing home residents with dementia: protocol for participatory action research in a stepped-wedge cluster randomized trial
por: Groot Kormelinck, Claudia M., et al.
Publicado: (2019)

Dementia and Parkinson’s Disease: Risk Factors for 30-Day Mortality in Nursing Home Residents with COVID-19
por: Rutten, Jeanine J.S., et al.
Publicado: (2021)

Cannabinoid as Beneficial Replacement Therapy for Psychotropics to Treat Neuropsychiatric Symptoms in Severe Alzheimer’s Dementia: A Clinical Case Report
por: Defrancesco, Michaela, et al.
Publicado: (2020)

An audit of the use of psychotropic medications over the course of admission to a specialist dementia ward
por: Singh, Sukhmeet, et al.
Publicado: (2021)

Multi-psychotropic drug prescription and the association to neuropsychiatric symptoms in three Norwegian nursing home cohorts between 2004 and 2011
por: Gulla, Christine, et al.
Publicado: (2016)

Prolonged neuropsychiatric effects following management of chloroquine intoxication with psychotropic polypharmacy
por: Maxwell, Nicole M, et al.
Publicado: (2015)

MANAGEMENT OF NONCOGNITIVE NEUROPSYCHIATRIC SYMPTOMS OF DEMENTIA IN NURSING HOME RESIDENTS
por: Basnet, Prasanna, et al.
Publicado: (2019)

Prescribing of psychotropic medication for nursing home residents with dementia: a general practitioner survey
por: Cousins, Justin M, et al.
Publicado: (2017)

Nurse Staffing and Nursing Home Deficiency of Care for Inappropriate Psychotropics Use in Residents With Dementia
por: Yoon, Jung Min, et al.
Publicado: (2020)

Dementia Care Training Regulations and Deficiencies of Care for Inappropriate Psychotropics Use in Nursing Homes
por: Yoon, Jung Min, et al.
Publicado: (2020)

Effect of caffeine on sleep and behaviour in nursing home residents with dementia
por: de Pooter-Stijnman, L. M. M., et al.
Publicado: (2018)

Risk of Death in Nursing Home Residents After COVID-19 Vaccination
por: Wouters, Fenne, et al.
Publicado: (2022)

FACTOR STRUCTURE OF NEUROPSYCHIATRIC SYMPTOM FREQUENCY IN HOME-RESIDING PERSONS WITH DEMENTIA
por: Hodgson, Nancy, et al.
Publicado: (2019)

PROPER I: frequency and appropriateness of psychotropic drugs use in nursing home patients and its associations: a study protocol
por: van der Spek, Klaas, et al.
Publicado: (2013)

Psychotropic medication prescribing in assisted living and nursing home residents with dementia after the National Partnership
por: Coe, Antoinette B., et al.
Publicado: (2022)

Psychotropic Medication Prescribing for Neuropsychiatric Comorbidities in Individuals Diagnosed with Autism Spectrum Disorder (ASD) in the UK
por: Alfageh, Basmah H., et al.
Publicado: (2019)

Neuropsychiatric symptoms and severity of dementia
por: Caldas, Gustavo Henrique de Oliveira, et al.
Publicado: (2013)

DIFFERENCES IN NEUROPSYCHIATRIC SYMPTOMS AMONG RACIAL AND ETHNIC GROUPS LIVING WITH DEMENTIA IN HOME HEALTHCARE
por: Lassell, Rebecca, et al.
Publicado: (2022)

Prescription Patterns of Anti-dementia and Psychotropic Drugs in People Living With Dementia in China
por: Yingyang, Zhang, et al.
Publicado: (2021)

Clinical Suspicion of COVID-19 in Nursing Home Residents: Symptoms and Mortality Risk Factors
por: Rutten, Jeanine J.S., et al.
Publicado: (2020)

Symptom- and Prevention-Based Testing of COVID-19 in Nursing Home Residents: A Retrospective Cohort Study
por: Paap, Kelly C., et al.
Publicado: (2021)

Biomarker Variability, Severity of CORADS and Impact of Psychotropic Medications on Course and Outcome of Neuropsychiatric Sequalae of COVID-19 ICU Patients: A Preliminary Observation from South India
por: Kandrakonda, S., et al.
Publicado: (2023)

The course of neuropsychiatric symptoms in nursing home residents from admission to 30-month follow-up
por: Helvik, Anne-Sofie, et al.
Publicado: (2018)

The construction of a conceptual framework explaining the relation between barriers to change of management of neuropsychiatric symptoms in nursing homes: a qualitative study using focus groups
por: van Teunenbroek, Charlotte F., et al.
Publicado: (2020)

Psychotropic and anti-dementia treatment in elderly persons with clinical signs of dementia with Lewy bodies: a cross-sectional study in 40 nursing homes in Sweden
por: Zahirovic, Iris, et al.
Publicado: (2018)

Access to a dementia-friendly garden on behavioural and psychological symptoms of dementia, falls and psychotropic medication use in residents of an aged care home in Melbourne, Australia
por: Lai, Rhoda, et al.
Publicado: (2023)

Implementation of a national testing policy in Dutch nursing homes during SARS‐CoV‐2 outbreaks
por: van den Besselaar, Judith H., et al.
Publicado: (2022)

Dutch: a course for beginners
por: Koolhoven, H
Publicado: (1961)

Prevalence and characteristics of neuropsychiatric symptoms, quality of life and psychotropics in people with acquired brain injury in long‐term care
por: Kohnen, Roy, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tne677mbqlmm5qln9coooakfpr